IRIS
Moroni, Gabriella Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.100
AS - Asia 4.025
SA - Sud America 945
EU - Europa 760
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 93
OC - Oceania 7
Totale 11.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.864
SG - Singapore 2.316
BR - Brasile 760
CN - Cina 646
VN - Vietnam 470
IT - Italia 354
HK - Hong Kong 207
CA - Canada 97
GB - Regno Unito 88
MX - Messico 74
AR - Argentina 72
IN - India 59
ID - Indonesia 48
BD - Bangladesh 43
DE - Germania 40
EC - Ecuador 38
FR - Francia 35
FI - Finlandia 27
IE - Irlanda 27
PL - Polonia 27
CO - Colombia 25
TR - Turchia 25
UA - Ucraina 24
PK - Pakistan 23
IQ - Iraq 22
JP - Giappone 21
MY - Malesia 20
ZA - Sudafrica 20
CR - Costa Rica 19
ES - Italia 18
PH - Filippine 18
AT - Austria 17
NL - Olanda 17
MA - Marocco 16
EG - Egitto 15
RU - Federazione Russa 15
CL - Cile 14
SE - Svezia 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
TN - Tunisia 12
SA - Arabia Saudita 11
KE - Kenya 9
PY - Paraguay 9
TH - Thailandia 9
AL - Albania 8
AZ - Azerbaigian 8
EE - Estonia 8
JM - Giamaica 8
JO - Giordania 7
PA - Panama 7
BG - Bulgaria 6
CH - Svizzera 6
UZ - Uzbekistan 6
BB - Barbados 5
HN - Honduras 5
KZ - Kazakistan 5
UY - Uruguay 5
ET - Etiopia 4
GT - Guatemala 4
IL - Israele 4
KG - Kirghizistan 4
KH - Cambogia 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
SV - El Salvador 4
BH - Bahrain 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LT - Lituania 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
IR - Iran 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
Totale 10.909
Salva come PNG Salva come JPEG
Città #
Singapore 996
San Jose 677
Ashburn 611
The Dalles 447
Council Bluffs 247
Beijing 211
Hong Kong 205
Dallas 188
Santa Clara 186
Ho Chi Minh City 160
Shanghai 139
Hanoi 115
New York 115
Milan 87
Los Angeles 84
São Paulo 62
Buffalo 54
Rome 52
Boardman 46
Mexico City 45
Phoenix 45
Brooklyn 38
Wilmington 34
Chicago 32
Naples 32
Assago 28
Helsinki 27
Warsaw 27
Dublin 25
Haiphong 22
Montreal 22
Atlanta 21
Princeton 21
Chandler 20
Da Nang 20
Philadelphia 20
Rio de Janeiro 20
Seattle 20
Tokyo 20
Brasília 19
Boston 18
Fort Worth 18
Houston 18
Queens 18
Washington 18
Miami 17
North Bergen 17
Orem 17
San José 15
Belo Horizonte 14
Charlotte 14
Curitiba 14
Hải Dương 13
Johannesburg 13
Quito 13
San Francisco 13
Toronto 13
Biên Hòa 12
Denver 12
Jakarta 12
Milwaukee 12
Kuala Lumpur 11
Springfield 11
Stockholm 11
Vienna 11
Campinas 10
Chennai 10
Las Vegas 10
Prineville 10
Salvador 10
San Mateo 10
Abbeville 9
Can Tho 9
Hillsboro 9
Istanbul 9
Mumbai 9
Orlando 9
Pasadena 9
Amsterdam 8
Baghdad 8
Baku 8
Buenos Aires 8
Cleveland 8
Guayaquil 8
Jacksonville 8
London 8
Nairobi 8
Newark 8
Nuremberg 8
Poplar 8
Reston 8
Saint Paul 8
San Diego 8
The Bronx 8
Thái Bình 8
Amman 7
Austin 7
Birmingham 7
Dhaka 7
Porto Alegre 7
Totale 5.889
Salva come PNG Salva come JPEG
Nome #
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 149
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 143
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 137
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 131
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 105
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study 100
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 99
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 98
Nephrotic syndrome: pathophysiology and consequences 96
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 93
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis 90
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 89
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 84
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 84
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 84
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 83
Acid-base balance and respiratory response during biofiltration with polyacrylonitrile membrane 81
Renal sarcoidosis 79
''Nephritic flares'' are predictors of bad long-term renal outcome in lupus nephritis 77
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 77
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 77
Is per-protocol kidney biopsy required in lupus nephritis? 76
ANCA-associated vasculitis in childhood: Recent advances 75
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy (vol 29, pg 277, 2016) 75
ANCA-associated vasculitis with renal involvement 74
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 74
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 74
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 72
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 72
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 70
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 68
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 68
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 67
Neutrophil Extracellular Traps in the Autoimmunity Context 65
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 65
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up 65
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 64
Renal replacement therapy in sarcoidosis 64
Monoclonal gammopathy in lupus nephritis 62
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 62
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 62
Anti-glomerular basement membrane vasculitis 61
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 61
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 61
Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature 60
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease 60
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 59
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 59
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review 59
Lupus nephritis: clinical presentations and outcomes in the 21st century 59
Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis 58
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management 58
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis 58
Anti-C1Q monitoring predicts relapses of lupus nephritis 58
Lupus Membranous Nephropathy 58
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 58
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 57
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 57
Autophagy: A Silent Protagonist in Kidney Transplantation 57
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 57
Lupus nephritis: When and how often to biopsy and what does it mean? 57
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up 56
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 56
Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 56
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis 56
Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases 55
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 55
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy 55
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 55
Anti-C1q Autoantibodies in Lupus Nephritis 55
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 55
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 54
Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults 53
Treatment of membranous lupus nephritis 53
Acute renal failure in a single kidney with previous obstruction 52
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 52
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 52
Old and new calcineurin inhibitors in lupus nephritis 52
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study 52
LES: Manifestazioni cliniche extra-renali E nefrite lupica 51
Alport syndrome and pregnancy: a case series and literature review 51
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 51
Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature 51
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 51
Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides) 50
How We Treat Dyslipidemia in Prolonged Nephrotic Syndrome 50
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? 50
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 50
Pregnancy in lupus nephritis 49
Immunosuppression in pregnant women with systemic lupus erythematosus 49
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease 49
Pregnancy after lupus nephritis 49
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 49
Rituximab therapy for primary glomerulonephritis: Report on two cases 48
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression 48
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 47
Is preeclampsia a risk for end-stage renal disease? 47
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort 47
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years 47
De Novo Glomerular Diseases after Renal Transplantation 47
Totale 6.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 4 2 2 1 3 0 2 4 1
2022/202371 7 2 5 7 4 4 2 4 6 5 4 21
2023/2024285 35 13 50 22 15 43 36 11 4 2 18 36
2024/20252.211 13 97 65 14 17 233 135 174 266 602 296 299
2025/20266.123 820 392 322 669 223 351 1.418 386 379 495 282 386
2026/20272.429 377 452 1.132 468 0 0 0 0 0 0 0 0
Totale 11.179